Autoimmune Diseases  >>  dimethyl fumarate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dimethyl fumarate / Generic mfg.
EXPLORE, NCT01156311: BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

Checkmark ACTRIMS 2014: MS
Jun 2014 - Jun 2014: ACTRIMS 2014: MS
Checkmark EFNS-ENS 2014: MS
May 2014 - May 2014: EFNS-ENS 2014: MS
Checkmark AAN 2014: Multiple sclerosis
More
Completed
2
108
US
dimethyl fumarate, Tecfidera, DMF, BG00012
Biogen
Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis
03/12
03/12
NCT02097849: Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

Completed
2
71
US
dimethyl fumarate, DMF, BG00012, Tecfidera, tetanus diphtheria toxoids vaccine, Td, Tenivac, 23-valent pneumococcal polysaccharide vaccine, Pneumovax 23, PPSV23, meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent), MCV4, Menveo, non-pegylated interferon, IFN
Biogen
Relapsing Forms of Multiple Sclerosis
05/16
05/16
FOCUS, NCT02410200 / 2014-005003-24: Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS

Completed
2
22
US, Europe, RoW
dimethyl fumarate, BG00012, DMF
Biogen
Multiple Sclerosis, Relapsing-Remitting
09/16
09/16

Download Options